Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention

Heart and Vessels

Volumn 24, Issue 4, 2009, Pages 267-270

  Gach, Olivier ^a   Louis, Olivier ^a   Chapelle, Jean Paul ^a   Vanbelle, Sophie ^b   Pierard, Luc A ^a   Legrand, Victor ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Embolization; Inflammation; Percutaneouscoronary intervention

Indexed keywords

C REACTIVE PROTEIN; DELTA TROPONIN; TROPONIN I; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; DEATH; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MUSCLE NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESTENOSIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY STENOSIS; FEMALE; HUMANS; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TROPONIN I;

EID: 68249156657     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1120-3     Document Type: Article

References (24)

1. Chen MC, Chen CJ, Yang CH, Wu CJ, Fang CY, Hsieh YK, Chang HW (2007) Interleukin-18: A strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart Vessels 22:371-375
2. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347(20):1557-1565
3. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
4. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417-424
5. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL (2002) Creactive protein and angiographic coronary artery disease: Independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39:632-637
6. Buffon A, Liuzzo G. Biasucci LM, Pasqueletti P, Ramazzotti V, Rebuzzi AG, Crea F, Maseri A (1999) Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 34:1512-1521
7. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiarello L, Gioffre PA (1998) Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 82:515-518
8. Gaspardone A, Ciavolella M, Carlizzi G, Xagoraris V, Romeo F, Gioffré PA (1982) Determinazione della proteina C-reattiva in cardiochirurgia: Importanza nel monitoraggio post-operatorio delle complicanze. Cardiologia 27:1121-1132
9. Gach O, Legrand V, Biessaux Y, Chapelle JP, Vanbelle S, Pierard LA (2007) Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. Am J Cardiol 99:31-35
10. Herrmann J, Von Birgelen C, Haude M, Volbracht L, Malyar N, Eggebrecht H, Konorza TF, Baumgart D, Erbel R (2002) Prognostic implication of cardiac troponin T increase following stent implantation. Heart 87:549-553
11. Nallamothu BK, Chetcuti S, Mukherjee D, Grossman PM, Kline-Rogers E, Werns SW, Bates ER, Moscucci M (2003) Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol 91:1272-1274
12. Cavallinin C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, Rubartelli P, Battaglia S, Niccoli L, Steffenino, Ardissino D (2005) Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study. Eur Heart J 26:1494-1498
13. Bhatt DL, Topol EJ. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? (2005) Circulation 112:906-915
14. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG (1996) Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 94:1528-1536
15. Prasad A, Singh M, Lerman A, Lennon RJ, Holmes DR, Rihal CS (2006) Isolated elevation in cardiac troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol 48:1765-1770
16. Heeschen C, Vanden Brand M, Hamm CW, Simoons ML (1999) Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation 104:1509-1514
17. Bhatt DL, Topol EJ (2002) Need to test the arterial inflammation hypothesis. Circulation 106:136-140
18. Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, Topol EJ, Ellis SG (2001) Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104: 992-997
19. Saadeddin SH, Habbab MA, Sobki SH, Ferns GA (2002) Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention. Am J Cardiol 89:981-983
20. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G (2004) Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 110:674-678
21. Sharma SK, Kini A, Marmur JD, Fuster V (2000) Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: Benefit is extended to improvement in intermediate-term survival. Circulation 102:166-172
22. Tardiff BE, Califf RM, Tcheng JE, Lincoff AM, Sigmon KN, Harrington RA, Mahaffey KW, Ohman EM, Teirstein PS, Blankenship JC, Kitt MM, Topol EJ (1999) Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol 33:88-96
23. Oka H, Ikeda S, Koga S, Miyahara Y, Kohno S (2008) Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. Heart Vessels 23:249-256
24. Iakovou I, Mintz GS, Dangas G, Abizaid A, Mehran R, Kobayashi Y, Lansky AJ, Aymong ED, Nikolsky E, Stone GW, Moses JW, Leon MB. (2003) Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 42:1900-1905